CEO and President
Mon, May 22, 2023
May 22
6,500 shares @ $25.79
Decreased holdings by -14.80%
11th largest trade (out of 107)
Trade made by an officer
10b5-1 scheduled trade
40% win rate · +5.4% median edge vs SPY (10 trades, 90-day · small sample)
Insider trade was 94% below market price
Price 32% above 200-day moving average
BTAIBioXcel Therapeutics, Inc.
HealthcareDrug Manufacturers - Specialty & Generic
1D0.00%
1W+5.34%
1M+12.20%
3M—
6M—
1Y—